Camostat, an oral trypsin inhibitor, reduces pancreatic fibrosis induced by repeated administration of a superoxide dismutase inhibitor in rats.

Yasuyuki Emori; Takaaki Mizushima; Naoki Matsumura; Koji Ochi; Hiroaki Tanioka; Akinori Shirahige; Mitsuko Ichimura; Toshiyuki Shinji; Norio Koide; Mitsune Tanimoto

doi:10.1111/j.1440-1746.2005.03826.x

Camostat, an oral trypsin inhibitor, reduces pancreatic fibrosis induced by repeated administration of a superoxide dismutase inhibitor in rats.

Identifier:nobleid.org/w1/20260515/AF84767C

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AF84767C.svg?ark=w1%2F20260515%2FAF84767C)](https://nobleid.org/work/w1/20260515/AF84767C)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Camostat, an oral trypsin inhibitor, reduces pancreatic fibrosis induced by repeated administration of a superoxide dismutase inhibitor in rats.

Identifier:nobleid.org/w1/20260515/AF84767C

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AF84767C.svg?ark=w1%2F20260515%2FAF84767C)](https://nobleid.org/work/w1/20260515/AF84767C)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work